ALNY
Price
$242.15
Change
-$4.43 (-1.80%)
Updated
Dec 18, 04:06 PM (EDT)
50 days until earnings call
CRIS
Price
$3.22
Change
-$0.23 (-6.67%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

ALNY vs CRIS

Header iconALNY vs CRIS Comparison
Open Charts ALNY vs CRISBanner chart's image
Alnylam Pharmaceuticals
Price$242.15
Change-$4.43 (-1.80%)
Volume$800
CapitalizationN/A
Curis
Price$3.22
Change-$0.23 (-6.67%)
Volume$254
CapitalizationN/A
ALNY vs CRIS Comparison Chart
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. CRIS commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Hold and CRIS is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ALNY: $246.58 vs. CRIS: $3.45)
Brand notoriety: ALNY and CRIS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 74% vs. CRIS: 66%
Market capitalization -- ALNY: $31.8B vs. CRIS: $27.26M
ALNY [@Biotechnology] is valued at $31.8B. CRIS’s [@Biotechnology] market capitalization is $27.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileCRIS’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • CRIS’s FA Score: 0 green, 5 red.
According to our system of comparison, ALNY is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 5 TA indicator(s) are bullish while CRIS’s TA Score has 2 bullish TA indicator(s).

  • ALNY’s TA Score: 5 bullish, 5 bearish.
  • CRIS’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ALNY is a better buy in the short-term than CRIS.

Price Growth

ALNY (@Biotechnology) experienced а -2.89% price change this week, while CRIS (@Biotechnology) price change was -12.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

ALNY is expected to report earnings on Feb 06, 2025.

CRIS is expected to report earnings on Nov 02, 2023.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($31.8B) has a higher market cap than CRIS($27.3M). ALNY YTD gains are higher at: 28.823 vs. CRIS (-72.941). CRIS has higher annual earnings (EBITDA): -44.56M vs. ALNY (-85.69M). ALNY has more cash in the bank: 2.78B vs. CRIS (20.9M). CRIS has less debt than ALNY: CRIS (3.26M) vs ALNY (1.3B). ALNY has higher revenues than CRIS: ALNY (2.1B) vs CRIS (10.3M).
ALNYCRISALNY / CRIS
Capitalization31.8B27.3M116,484%
EBITDA-85.69M-44.56M192%
Gain YTD28.823-72.941-40%
P/E RatioN/AN/A-
Revenue2.1B10.3M20,340%
Total Cash2.78B20.9M13,301%
Total Debt1.3B3.26M39,939%
FUNDAMENTALS RATINGS
ALNY vs CRIS: Fundamental Ratings
ALNY
CRIS
OUTLOOK RATING
1..100
852
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
22100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4492
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRIS's Valuation (64) in the Biotechnology industry is somewhat better than the same rating for ALNY (99). This means that CRIS’s stock grew somewhat faster than ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (22) in the Biotechnology industry is significantly better than the same rating for CRIS (100). This means that ALNY’s stock grew significantly faster than CRIS’s over the last 12 months.

ALNY's SMR Rating (100) in the Biotechnology industry is in the same range as CRIS (100). This means that ALNY’s stock grew similarly to CRIS’s over the last 12 months.

ALNY's Price Growth Rating (44) in the Biotechnology industry is somewhat better than the same rating for CRIS (92). This means that ALNY’s stock grew somewhat faster than CRIS’s over the last 12 months.

ALNY's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CRIS (100). This means that ALNY’s stock grew similarly to CRIS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYCRIS
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 22 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
68%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCTX0.650.04
+6.17%
BriaCell Therapeutics Corp
CCEP77.550.12
+0.15%
Coca-Cola Europacific Partners plc
BRZE44.75-0.03
-0.07%
Braze
FSM4.60-0.04
-0.86%
Fortuna Mining Corp
BMRC24.60-0.23
-0.93%
Bank of Marin Bancorp

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
+1.06%
IONS - ALNY
49%
Loosely correlated
-1.10%
ATRA - ALNY
44%
Loosely correlated
-1.52%
SGMO - ALNY
42%
Loosely correlated
+6.62%
AMLX - ALNY
40%
Loosely correlated
+2.39%
VXRT - ALNY
40%
Loosely correlated
+0.99%
More